Breath Diagnostics

United States
Aviston, Illinois, United States, 40059

Company profile

Breath Diagnostics company profile

Breath Diagnostics's mission is to globally implement breath analysis technology to provide early detection for cancers and reduce patient exposure to costly, high risk medical procedures. They have developed a patented technology that will determine if a patient has lung cancer by analyzing a patient’s breath with parts per billion accuracy, allowing very early detection. They have studied over 700 patients. This has the potential to save a significant number of lives and save the healthcare industry significant dollars.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2014-01-01, Year

Headquarters

Postal code
40059
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
3
Last funding
Series Unknown / 2020-03-11
Last equity funding
Series Unknown
Investors
3
Lead investors
3
Founders
4
Articles
5

Founders and investors

Founders

Michael BousamraMichael NantzVictor van BerkelXiao-An Fu

Lead investors

HealthXCapitalNational Science FoundationThe Vogt Awards

Investors

HealthXCapitalNational Science FoundationThe Vogt Awards